Company intelligence / Profile preview

BMS Consulting

Princeton, New Jersey, United States

Ownership: Private
Employees: ~30000
Development stage: Other

Overview

Bristol Myers Squibb has an extensive commercial portfolio with over 280 marketed drugs and hundreds of clinical programs. Notable recent clinical results include the approval of Abecma for multiple myeloma in partnership with 2seventy bio. However, some programs have faced competitive pressures or trial discontinuations due to evolving standards of care. The company continues to invest heavily in oncology/immunology innovation while managing patent cliffs on key products like Eliquis and Opdivo.

Therapeutic areas: OncologyCardiovascularImmunologyHematology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateCell therapy (including CAR-T cell therapy)Protein (e.g., recombinant protein therapies)BiologicPeptides
Industry: Pharma

Partnerships

bluebird bio /2seventy bio – co-development of Abecma CAR-T therapy for multiple myelomaVarious academic institutions and biotech partners globally

Beyond the preview

Go deeper on BMS Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BMS Consulting.

Explore the full profile